The Economic Impact of Pharmaceutical Parallel Trade in European Union Member States: A Stakeholder Analysis

Abstract

• Direct savings accruing to statutory health insurance organisations from the conduct of parallel trade are modest both in absolute and relative terms. These savings (in € ‘000) are as follows for 2002: Norway Germany Sweden Denmark UK Netherlands € € % Total market % Total market 563 0.3% 17,730 0.8% 3,770 1.3% 3,002 2.2% 6,887 55,887 0.3% 2.8% 12,762 19,119 2.2% 3.6% Note: 1 Includes estimates for the clawback.